Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000099

Chief Medical Officer sold 20,407 shares at an average $27.28 ($556,671)

  • Chief Medical Officer acquired 14,058 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-07-13 Option exercise 10b5-1 +3,542 $10.20 $36,128 61,275 D
Rodman David Malcom Chief Medical Officer 2026-07-13 Option exercise 10b5-1 +4,167 $14.25 $59,380 65,442 D
Rodman David Malcom Chief Medical Officer 2026-07-13 Option exercise 10b5-1 +6,349 $1.08 $6,857 71,791 D
Rodman David Malcom Chief Medical Officer 2026-07-13 Sale 10b5-1 −14,058 $27.58 $387,717 57,733 D
Rodman David Malcom Chief Medical Officer 2026-07-15 Sale 10b5-1 −6,349 $26.61 $168,955 51,384 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-07-13 Option exercise · Stock Option 10b5-1 −3,542 109,792 D
Rodman David Malcom Chief Medical Officer 2026-07-13 Option exercise · Stock Option 10b5-1 −4,167 79,167 D
Rodman David Malcom Chief Medical Officer 2026-07-13 Option exercise · Stock Option 10b5-1 −6,349 0 D
Open-market sales · 20,407 sh · avg $27.28 · $556,671
Loading xslF345X06/wk-form4_1784163485.xml…